Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jae Keith Joung, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Jae Joung and Luca Pinello.
Connection Strength

2.676
  1. Augmenting and directing long-range CRISPR-mediated activation in human cells. Nat Methods. 2021 09; 18(9):1075-1081.
    View in: PubMed
    Score: 0.238
  2. PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nat Commun. 2021 02 15; 12(1):1034.
    View in: PubMed
    Score: 0.230
  3. A Code of Ethics for Gene Drive Research. CRISPR J. 2021 02; 4(1):19-24.
    View in: PubMed
    Score: 0.230
  4. Technologies and Computational Analysis Strategies for CRISPR Applications. Mol Cell. 2020 07 02; 79(1):11-29.
    View in: PubMed
    Score: 0.220
  5. Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2020 Jul; 38(7):901.
    View in: PubMed
    Score: 0.220
  6. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol. 2019 03; 37(3):224-226.
    View in: PubMed
    Score: 0.201
  7. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat Biotechnol. 2019 03; 37(3):276-282.
    View in: PubMed
    Score: 0.200
  8. CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data. Nat Methods. 2018 12; 15(12):992-993.
    View in: PubMed
    Score: 0.198
  9. In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature. 2018 09; 561(7723):416-419.
    View in: PubMed
    Score: 0.195
  10. An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. Nat Biotechnol. 2018 11; 36(10):977-982.
    View in: PubMed
    Score: 0.193
  11. Impact of Genetic Variation on CRISPR-Cas Targeting. CRISPR J. 2018 04; 1(2):159-170.
    View in: PubMed
    Score: 0.189
  12. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo". Nat Methods. 2018 04; 15(4):238-239.
    View in: PubMed
    Score: 0.189
  13. Author Correction: CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nat Biotechnol. 2022 Feb; 40(2):273.
    View in: PubMed
    Score: 0.062
  14. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nat Biotechnol. 2022 Feb; 40(2):189-193.
    View in: PubMed
    Score: 0.058
  15. Therapeutic base editing of human hematopoietic stem cells. Nat Med. 2020 04; 26(4):535-541.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.